Literature DB >> 22492700

Trends in cancer mortality in China: an update.

P Guo1, Z L Huang, P Yu, K Li.   

Abstract

BACKGROUND: Cancer deaths of China with the world population nearly a quarter will have a severe impact on global cancer trend and burden. The study aims to provide a comprehensive overview of long-term trends in cancer mortality in China.
MATERIALS AND METHODS: We used joinpoint analysis to detect changes in trends and generalized additive models to study birth cohort effect of risk factors between 1987 and 2009.
RESULTS: Mortality of all cancers declined steadily in urban areas, but not in rural areas. Decreasing mortality from cancers of the stomach, esophagus, nasopharynx, and cervix uteri was observed, while lung and female breast cancer mortality increased. Mortality from leukemia remained relatively stable, and cancer of liver, colorectal, and bladder had different trends between the rural and urban areas. Generational risks peaked in the cohorts born around 1925-1930 and tended to decline in successive cohorts for most cancers except for leukemia, whose relative risks were rising in the very recent cohorts.
CONCLUSION: The observed trends primarily reflect dramatic changes in socioeconomic development and lifestyle in China over the past two decades, and mortality from cancers of lung and female breast still represents a major public health priority for the government.

Entities:  

Mesh:

Year:  2012        PMID: 22492700     DOI: 10.1093/annonc/mds069

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  80 in total

1.  Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.

Authors:  Zhen Wang; Hong-Hong Yan; Jin-Ji Yang; Bin-Chao Wang; Hua-Jun Chen; Qing Zhou; Chong-Rui Xu; Ben-Yuan Jiang; Yi-Long Wu
Journal:  Support Care Cancer       Date:  2014-08-27       Impact factor: 3.603

2.  CRR9p polymorphism as a protective factor for lung cancer.

Authors:  Yang Chen; Zhiguo Yu; Bo Zhang; Zhengqi Chang; Hong Wang; Zhandi Liu
Journal:  Tumour Biol       Date:  2014-06-24

3.  Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.

Authors:  Qing-Kun Song; Xiao-Li Wang; Xin-Na Zhou; Hua-Bing Yang; Yu-Chen Li; Jiang-Ping Wu; Jun Ren; Herbert Kim Lyerly
Journal:  Oncologist       Date:  2015-05-22

4.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.

Authors:  Ajay A Myneni; Shen-Chih Chang; Rungui Niu; Li Liu; Heather M Ochs-Balcom; Yanli Li; Chao Zhang; Baoxing Zhao; Jianping Shi; Xiaoyou Han; Jiawei Li; Jia Su; Lin Cai; Shunzhang Yu; Zuo-Feng Zhang; Lina Mu
Journal:  Lung Cancer       Date:  2013-02-19       Impact factor: 5.705

5.  Ecological study of gastric cancer in Brazil: geographic and time trend analysis.

Authors:  César Augusto Amorim; Jéssica Pronestino Moreira; Luisa Rial; Antonio José Carneiro; Homero Soares Fogaça; Celeste Elia; Ronir Raggio Luiz; Heitor Siffert Pereira de Souza
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

6.  Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.

Authors:  Rui-Juan Wang; Yan-Hua Zheng; Ping Wang; Jian-Zhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 7.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

8.  Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.

Authors:  Zongtang Sun; Taoyang Chen; Snorri S Thorgeirsson; Qimin Zhan; Jianguo Chen; Ju-Hyun Park; Peixin Lu; Chu Chieh Hsia; Nengjin Wang; Libin Xu; Lingling Lu; Fei Huang; Yuanrong Zhu; Jianhua Lu; Zhengping Ni; Qinan Zhang; Yuying Wu; Guoting Liu; Zhiyuan Wu; Chunfeng Qu; Mitchell H Gail
Journal:  Carcinogenesis       Date:  2013-01-14       Impact factor: 4.944

9.  4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Authors:  Qin Yang; Min Zhu; Zi Wang; Hui Li; Weihua Zhou; Xiaojuan Xiao; Bin Zhang; Weixin Hu; Jing Liu
Journal:  Tumour Biol       Date:  2016-07-22

10.  Specificity may count: not every aspect of coping self-efficacy is beneficial to quality of life among Chinese cancer survivors in China.

Authors:  Nelson C Y Yeung; Qian Lu; Wenjuan Lin
Journal:  Int J Behav Med       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.